FDA Inspection 1280450 - Sparsha Pharma Usa Inc - September 04, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sparsha Pharma Usa Inc

Record Details

This FDA Inspection record concerns Sparsha Pharma Usa Inc, with an inspection on September 4, 2025, issued by the Los Angeles District Office, covering human drugs.

Company: Sparsha Pharma Usa Inc
Inspection Date: September 4, 2025
Product Type: Human Drugs
Office: Los Angeles District Office

Open in Dashboard

ID · 4c28f907-5cd5-405c-a8ca-e5fbd00313fb

Violation Codes10

21 CFR 211.14221 CFR 211.160(a)21 CFR 211.160(b)(2)21 CFR 211.165(e)21 CFR 211.188(b)(7)21 CFR 211.19221 CFR 211.194(a)21 CFR 211.68(b)21 CFR 820.100(b)21 CFR 820.20(b)

Full citation text and observation details available on the Dashboard.